(Q37803527)

23 August 2017

title

Acceptance of biomarker-based tests for application in clinical practice: criteria and obstacles (English)

1 reference

23 August 2017

0 references

M Pirmohamed

1

0 references

language of work or name

English

0 references

publication date

27 October 2010

1 reference

Clinical Pharmacology & Therapeutics

23 August 2017

published in

1 reference

23 August 2017

volume

88

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

862-866

1 reference

Shattuck lecture--clinical research to clinical practice--lost in translation?

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Curses--winner's and otherwise--in genetic epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

STrengthening the REporting of Genetic Association Studies (STREGA): an extension of the STROBE statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

A new system for grading recommendations in evidence based guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

De testimonio: on the evidence for decisions about the use of therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Medical genetics: a marker for Stevens-Johnson syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

From best evidence to best practice: effective implementation of change in patients' care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Pharmacogenetics of warfarin: current status and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Estimation of the warfarin dose with clinical and pharmacogenetic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

HLA-B*5701 screening for hypersensitivity to abacavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

21 January 2018

When Drugs Don??t Work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

Translation of highly promising basic science research into clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

7 January 2021

Testing challenges: evaluation of novel diagnostics and molecular biomarkers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

7 January 2021

FDA drug prescribing warnings: is the black box half empty or half full?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

7 January 2021

Pharmacogenetics of idiosyncratic adverse drug reactions

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2010.245

7 January 2021

Identifiers

DOI

10.1038/CLPT.2010.245

1 reference

23 August 2017

1 reference